Shree Ganesh Bio-Tech (India) Limited is an established Indian agricultural enterprise specializing in the high-growth **seed technology sector**. The company operates a vertically integrated business model that spans the entire value chain of agricultural productivity, from the **production and specialized processing** of seeds to their **marketing and distribution** across domestic markets. --- ### **Core Product Portfolio & Revenue Drivers** The company’s financial performance is tied exclusively to the agricultural sector, with **100% of total revenue** generated from its hybrid seed activities. It operates through a **single primary segment**, focusing on high-yield varieties that cater to essential food and industrial crops. **Primary Hybrid Seed Varieties:** * **Cereals & Grains:** Corn, Paddy, and Grain Sorghum. * **Oilseeds:** Sunflower. * **Fiber Crops:** Cotton. The business model relies on a **project execution framework** where production is often managed through third-party contractors. This strategic choice ensures the company is **not exposed to commodity price risk**, as the contractual nature of these engagements provides a buffer against the volatility of raw agricultural commodity markets. --- ### **Capital Structure & Exchange Listings** Shree Ganesh Bio-Tech maintains a broad presence across Indian capital markets, ensuring liquidity and accessibility for a diverse investor base. The company has transitioned to a modern financial framework with **compulsory dematerialization** of shares through agreements with both **NSDL** and **CDSL**. | Capital Metric | Value / Detail | | :--- | :--- | | **Authorized Share Capital** | **Rs. 40,00,00,000** (40 Cr Equity Shares) | | **Paid-up Share Capital** | **Rs. 39,86,24,000** (39.86 Cr Equity Shares) | | **Face Value** | **Rs. 1 per share** | | **Primary Listings** | **BSE Limited**, **The Calcutta Stock Exchange Ltd**, **MSE India Limited** | **Financial Management Policy:** In recent fiscal cycles, the company has opted for a conservative capital preservation strategy, choosing to **retain earnings** to support operational liquidity rather than declaring dividends or transferring significant sums to general reserves. --- ### **Operational Infrastructure & Asset Management** The company maintains a lean but structured operational footprint. Management emphasizes the integrity of its physical and intangible assets through the following protocols: * **Asset Accounting:** The company maintains comprehensive records of **Property, Plant and Equipment (PPE)** and **Intangible Assets**. * **Inventory Control:** Management performs **periodic physical verification** of seed stocks. While some reporting periods have shown zero inventory, current protocols ensure that physical stocks are reconciled with book records to maintain transparency in supply chain reporting. * **Banking Infrastructure:** Core financial operations and credit facilities are managed through Tier-1 institutional partners, specifically the **Central Bank of India** and **Bank of India**. --- ### **Strategic Leadership Competencies** The Board of Directors is structured to provide a multidisciplinary approach to the agricultural business, focusing on five key pillars of expertise: 1. **Project Management:** Ensuring the timely delivery of specialized seed processing equipment and the expansion of facility capacities. 2. **Sales & Distribution:** Deep expertise in **B2B sales** and account management to penetrate regional agricultural markets. 3. **Supply Chain Optimization:** Oversight of manufacturing workflows and seed production facilities. 4. **International Scaling:** Strategic experience in evaluating and entering new geographical markets outside of India. 5. **Corporate Governance:** Navigating the regulatory requirements of multiple stock exchange listings. --- ### **Critical Risk Assessment & Regulatory Compliance** Investors should note that Shree Ganesh Bio-Tech has faced significant challenges regarding **internal controls and regulatory adherence**. While the company has reported **no penalties** from capital market regulators in the last **three years**, several procedural lapses have been flagged by **BSE Limited** and **SEBI**. #### **1. Internal Control & Audit Gaps** * **Internal Auditor Vacancy:** Contrary to **Section 138 of the Companies Act, 2013**, the company has failed to appoint an **Internal Auditor** as of **August 2025**. * **Structured Digital Database (SDD):** The company was labeled **SDD non-compliant** in **January 2024** after failing to facilitate a virtual inspection of its insider trading tracking software by the exchange. #### **2. Disclosure & Transparency Issues** * **Statutory Advertisements:** The company has been non-compliant with **SEBI (LODR) Regulation 47**, failing to publish mandatory notices for **Board Meetings, AGMs, and Quarterly Results** in national and regional newspapers. * **Misrepresentation Warnings:** The company received a warning regarding **Regulation 4(1)(c)** for providing misleading information to exchanges. This included misreporting the designation of Executive Director **Mr. Kishan Naidu** for several quarters between **2022 and 2023**. #### **3. Governance & Administrative Oversight** * **Director Identification Number (DIN) Deactivation:** The **MCA** deactivated the DINs of Executive Director **Mr. Kishan Naidu** and former Independent Director **Ms. Chandni Solanki** due to the non-filing of **DIR-3 KYC**. While the company views this as an individual responsibility, regulators have flagged it as a systemic governance failure. * **Tax Compliance Review:** Secretarial audits have noted that compliance with direct and indirect tax laws is not currently reviewed within the secretarial scope, being deferred entirely to statutory financial audits. ### **Risk Summary Table** | Risk Factor | Status | Impact on Investors | | :--- | :--- | :--- | | **Commodity Price Risk** | **Mitigated** | Low; protected by third-party contract model. | | **Regulatory Compliance** | **High Risk** | Potential for future fines or trading suspensions due to SDD and LODR lapses. | | **Internal Audit** | **Deficient** | Lack of independent internal oversight on financial processes. | | **Related Party Transactions** | **Clean** | No reported transactions conflicting with shareholder interests. | | **Information Integrity** | **Cautionary** | History of misreporting director designations and filing inconsistencies. |